Press Release Summary:
Constructed to keep in line with US FDA recommendations, soft and firm di-2-ethylhexyl phthalate (DEHP)-free catheters are engineered specifically to improve patient outcomes following thoracic drainage intervention. Extrusion design promotes patient comfort and surgical placement while providing favorable atraumatic insertion technique. Other features include depth markings for accurate placement; tapered oval drainage eyes; and gentle, spiral hole configuration.
Original Press Release:
Atrium Medical Announces its PVC Catheters are DEHP-Free
HUDSON, N.H., Aug. 6 -- Atrium Medical Corporation is pleased to announce that our soft and firm PVC Catheters are DEHP-Free.
Atrium is the number one manufacturer of chest drainage products worldwide, and offers the most complete selection of innovative drainage products, including chest tube insertion kits designed for patient ambulation following open heart and thoracic surgery, and late breaking technologies for soft tissue repair. As part of its commitment to best quality, Atrium is pleased to announce the availability of its di-2-ethylhexyl phthalate (DEHP) free thoracic catheters.
In keeping with the US Food and Drug Administration (FDA) recommendation that medical device manufacturers reformulate products to remove DEHP, and further suggest that all hospitals use alternatives to DEHP containing products, Atrium is ready to satisfy this new clinical requirement.
DEHP-free catheters are Atrium's latest advance in a series of unique medical device innovations, built upon a strong 26 year heritage of excellence in advanced biomaterial science, all engineered specifically for improvements in patient outcomes following thoracic drainage intervention.
Atrium Medical Corporation of Hudson, New Hampshire, is known for its quality in developing medical device technologies for the treatment of cardiovascular disease, significant investments in a diversified portfolio of therapeutic platforms, has brought a number of breakthrough advances in several diversified healthcare markets, including cardiology, chest trauma care and thoracic drainage, vascular surgery, hernia and soft tissue repair. Maintaining a commitment to the latest ISO13485 Quality Standards, state-of- the-art manufacturing and automation, cell biology and biomaterial discovery programs, Atrium continues to excel in several specialty healthcare markets requiring surgical intervention. For more information call 800-370-7899 or visit Atrium's website www.atriummed.com.
CONTACT: Kelly MacMillan, Marketing Communications Manager of Atrium Medical Corporation, +1-603-880-1433 x5209, or fax, +1-603-880-4545, email@example.com